Advertisement
Monday, Oct 18, 2021
Outlook.com
Outlook.com

Gennova''s mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials

Gennova''s mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials
outlookindia.com
1970-01-01T05:30:00+0530
New Delhi, Aug 24 (PTI) India''s first mRNA-based COVID-19 vaccine candidate HGCO19 by Gennova Biopharmaceuticals Ltd has been granted approval for Phase 2/3 clinical trails, the Department of Biotechnology (DBT) said on Tuesday.

The Pune-based biotechnology company had submitted the interim clinical data of the vaccine''s Phase 1 study to the Central Drugs Standard Control Organisation (CDSCO), it said.

The Vaccine Subject Expert Committee (SEC) reviewed the interim Phase 1 data and found that the HGCO19 vaccine was safe, tolerable, and immunogenic in the participants of the study.

"Gennova submitted the proposed Phase 2 and Phase 3 study entitled ''A Prospective, Multicentre, Randomised, Active-controlled, Observer-blind, Phase 2 study seamlessly followed by a Phase 3 study to evaluate the Safety, Tolerability, and Immunogenicity of the candidate HGCO19 (COVID-19 vaccine) in healthy subjects'' which was approved by the office of the DCG(I), CDSCO," the DBT said.

The study will be conducted in the country at approximately 10-15 sites in Phase 2 and 22-27 sites in Phase 3. Gennova plans to use the DBT-ICMR clinical trial network sites for this study, it said.

Gennova''s mRNA-based COVID-19 vaccine development programme was partly funded by the DBT under Ind CEPI in June 2020.

Later on, the DBT further supported the programme under ''Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission'', implemented by BIRAC.

Renu Swarup, Secretary of DBT and Chairperson of Biotechnology Industrial Research Assistance Council (BIRAC), said this is an important milestone in the country''s indigenous vaccine development mission, and it positions India on the global map for novel vaccine development.

Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd, said, "After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase 1 clinical trial, Gennova''s focus is to start Phase 2/3 pivotal clinical trial.

"In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation''s vaccine requirement," he said. PTI PR IJT


Disclaimer :- This story has not been edited by Outlook staff and is auto-generated from news agency feeds. Source: PTI

More from Website

BAN Vs SCO, ICC T20 World Cup 2021: Scotland Stun Bangladesh On First Day Of Tournament

BAN Vs SCO, ICC T20 World Cup 2021: Scotland Stun Bangladesh On First Day Of Tournament

This is Scotland's second win in a World Cup, the first coming in the 2016 edition of the tournament against Hong Kong.

Indonesia Beat China To Lift Thomas Cup Trophy After 19 Years

Indonesia Beat China To Lift Thomas Cup Trophy After 19 Years

Indonesia are the most successful nation in the history of the team championship of men's badminton with 14 titles.

Bayern Munich Beat Leverkusen 5-1 To Go Top Of German Bundesliga

Bayern Munich Beat Leverkusen 5-1 To Go Top Of German Bundesliga

Four goals in seven minutes left Leverkusen in tatters before half-time as Bayern made a statement win to underline why it's chasing a 10th consecutive title.

More from Outlook Magazine

An Unfolding Dalit Movement In Tamil Nadu Has Escaped Nation’s Attention

An Unfolding Dalit Movement In Tamil Nadu Has Escaped Nation’s Attention

Poet and activist Meena Kandasamy visits ground zero of the grassroots movement down South to understand the caste divide in the state.

India Needs A Caste Census To Know Where The Marginalised Stand In The Development Index

India Needs A Caste Census To Know Where The Marginalised Stand In The Development Index

The aim of a caste census is not to know the numerical strength of a caste. Rather, it would reveal social inequalities for possible remedial measures.

Lakhimpur Kheri: Heartbreak And Tears As Families Try To Cope With Personal Grief

Lakhimpur Kheri: Heartbreak And Tears As Families Try To Cope With Personal Grief

Kin of killed farmers, BJP members have the same demand—justice for the dead.

Advertisement

Outlook Newsletters

Advertisement
Advertisement